Page last updated: 2024-08-23

simvastatin and Hematologic Malignancies

simvastatin has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agha, ME; Monaghan, SA; Swerdlow, SH	1

Other Studies

1 other study(ies) available for simvastatin and Hematologic Malignancies

Article	Year
Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm. The New England journal of medicine, 2018, Oct-11, Volume: 379, Issue:15 Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Female; Hematologic Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Simvastatin; Skin Neoplasms; Sulfonamides	2018

Article

Year

Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm.

The New England journal of medicine, 2018, Oct-11, Volume: 379, Issue:15

Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Female; Hematologic Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Simvastatin; Skin Neoplasms; Sulfonamides

2018